[Gastrointestinal endocrine cells during the treatment of duodenal ulcer patients with the new peptide preparation dalargin].
D001078:APUD Cells / Q000187:drug effects* / Q000473:pathology; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001706:Biopsy; D004064:Digestive System / Q000187:drug effects* / Q000473:pathology; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000473:pathology; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D006801:Humans
D000897:Anti-Ulcer Agents; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Gastrointestinal'nye éndokrinnye kletki pri lechenii bol'nykh duodenal'noĭ iazvoĭ novym peptidnym preparatom dalarginom.